Dudediligence.

Cue Biopharma, Inc

CUENASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.3MSep ’24$1.6MDec ’24$421,000Mar ’25$3.0MJun ’25$2.1MSep ’25$21.9MDec ’25$5.7MMar ’26$7.9MJun ’26
Net income, by quarter
−$8.7MSep ’24−$9.5MDec ’24−$12.3MMar ’25−$8.5MJun ’25−$7.4MSep ’25$1.6MDec ’25−$5.2MMar ’26−$153.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$14.9M$1.2M$5.5M$9.3M$27.5M
Operating income−$43.7M−$53.2M−$52.1M−$41.5M−$26.6M
Net income−$44.2M−$53.0M−$50.7M−$40.7M−$26.6M
Operating cash flow−$38.8M−$41.8M−$40.0M−$36.3M−$21.7M
Free cash flow−$39.8M−$42.0M−$40.0M−$36.4M−$21.9M
Cash$64.4M$51.6M$48.5M$22.5M$27.1M
Debt$0.00$10.0M$8.2M$0.00none on file
Shares outstanding32.2M47.2M47.2M61.8M96.6M